Press "Enter" to skip to content

Patent delisted for Abbvie drug KALETRA

0
Copyright © DrugPatentWatch. Originally published at Patent delisted for Abbvie drug KALETRA

Annual Drug Patent Expirations for KALETRA
Kaletra is a drug marketed by Abbvie and is included in three NDAs. It is available from three suppliers.

KALETRA drug price trends.

Drug patent litigation for KALETRA.

The generic ingredient in KALETRA is lopinavir; ritonavir. Three suppliers are listed for this compound. Additional details are available on the lopinavir; ritonavir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at Patent delisted for Abbvie drug KALETRA
DrugPatentWatch - Make Better Decisions